The Company provides devices for performing aneurysm repairs. The company is also pursuing development for a thoracic aortic aneurysm (TAA) repair system and further innovation of its abdominal aortic aneurysm (AAA) repair system. develops and manufactures medical devices. regulatory processes related to the Aptus EndoStapling System as both a stand-alone product and as part of the Aptus Endovascular AAA Repair System. Bolton Medical Inc Johnson & Johnson Jotec Gmb Lombard Medical Technologies plc Terumo Inc TriVascular Technologies Inc Gore Medical Altura Medical Aptus Endosystems Braile Biomédica B Braun Lifetech Scientific Johnson & Johnson In Chapter 5 and Chapter 7. The new capital will be used to advance clinical and commercial development in Europe and continue the U.S.
APTUS ENDOSYSTEMS INC TRIAL
II trial of the Aptus Endovascular Abdominal Aortic Aneurysm (AAA) Repair. It includes both a proprietary Endograft and the EndoStapling System.ĭuring 2010, the company obtained the CE Mark for the system X Aortic Endoanchors (Aptus Endosystems, Inc., Sunnyvale, CA) placed. Venture Partners and Longitude Capital.įounded in 2002, Aptus is developing the Aptus Endovascular AAA Repair System, which provides an alternative to open surgical repair by separating the functions of aneurysm exclusion and endograft fixation. develops and manufactures medical devices. Aptus Endosystems, Inc., a Sunnyvale, CA-based medical device company developing advanced technology for endovascular aneurysm repair (EVAR), completed a $15m Series “AA” financing.
0 kommentar(er)
